Latest Transenterix Inc. (TRXC) Headlines TransEn
Post# of 61
TransEnterix, Inc. Reports Operating Results for the Fourth Quarter and Full Year 2013
Business Wire - Wed Mar 05, 6:00AM CST
TransEnterix, Inc. (OTCBB:TRXC), a medical device company that is pioneering the use of flexible instruments and robotics to improve how minimally invasive surgery is performed, today announced its operating and financial results for the fourth quarter and full year 2013, as well as its 2014 key objectives.
CORRECTING and REPLACING TransEnterix Schedules Fourth Quarter and Full Year 2013 Earnings Release and Conference Call for March 5, 2014
Business Wire - Wed Feb 26, 4:23PM CST
First graph, end of second sentence of release should read: ...starting at 8:00 am Eastern Time the same day. (sted ...starting at 1:00 pm Eastern Time the same day.).
TransEnterix Schedules Fourth Quarter and Full Year 2013 Earnings Release and Conference Call for March 5, 2014
Business Wire - Wed Feb 26, 3:56PM CST
TransEnterix, Inc. (OTCBB: TRXC) announced today that it plans to release fourth quarter and full year 2013 financial and operating results prior to the market open on Wednesday, March 5, 2014. Todd Pope, Chief Executive Officer and Joe Slattery, Executive Vice President and Chief Financial Officer will host a conference call to discuss these resulting starting at 1:00 pm Eastern Time the same day. The call will be concurrently webcast.
TransEnterix, Inc. to present at the RBC Capital Markets 2014 Healthcare Conference
Business Wire - Tue Feb 11, 3:32PM CST
TransEnterix, Inc. (OTCBB:TRXC) announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the RBC Capital Markets 2014 Healthcare Conference in New York. The presentation is scheduled to take place at 2:35 pm Eastern Time on Tuesday, February 25, 2014.
TransEnterix Enters Next Phase of Development of SurgiBot(TM) System
Business Wire - Mon Jan 13, 6:00AM CST
TransEnterix, Inc. (OTCBB: TRXC), a medical device company that is pioneering the use of flexible instruments and robotics to improve minimally invasive surgery, today announced that multiple surgeons have used SurgiBot, the company's patient-side minimally invasive robotic system, to successfully complete general surgery procedures in the porcine model. The procedures performed in the pre-clinical testing included cholecystectomy and sleeve gastrectomy.